Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry-Reference-Cited by-同舟云学术

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

Published:2012-10 Issue:10 Volume:27 Page:3807-3815
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Kielstein Jan T.,Beutel Gernot,Fleig Susanne,Steinhoff Jürgen,Meyer Tobias N.,Hafer Carsten,Kuhlmann Uwe,Bramstedt Jörn,Panzer Ulf,Vischedyk Martin,Busch Veit,Ries Wolfgang,Mitzner Steffen,Mees Stefan,Stracke Sylvia,Nürnberger Jens,Gerke Peter,Wiesner Monika,Sucke Bernd,Abu-Tair Miriam,Kribben Andreas,Klause Norbert,Schindler Ralf,Merkel Frank,Schnatter Sabine,Dorresteijn Eiske M.,Samuelsson Ola,Brunkhorst Reinhard

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/27/10/3807/17108523/gfs394.pdf

Reference42 articles.

1. Large and ongoing outbreak of haemolytic uraemic syndrome, Germany, May 2011;Frank;Euro Surveill,2011

2. EHEC/HUS O104:H4—The outbreak is considered to be over;Robert-Koch-Institut

3. German outbreak of Escherichia coli O104:H4 associated with sprouts;Buchholz;N Engl J Med,2011

4. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study;Bielaszewska;Lancet Infect Dis,2011

5. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany;Rasko;N Engl J Med,2011

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two cases of typical HUS in adults treated with an anti-C5 monoclonal antibody: a new perspective?;Journal of Nephrology;2024-07-29

2. Risk factors of death or chronic renal replacement therapy requirements in patients with thrombotic microangiopathies without ADAMTS‐13 deficiency;European Journal of Haematology;2024-07-02

3. Nierenbeteiligung bei thrombotischer Mikroangiopathie;Nephrologie aktuell;2024-07

4. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference;Kidney International;2024-06

5. Eculizumab for Shiga‐toxin‐induced hemolytic uremic syndrome in adults with neurological involvement;eJHaem;2024-04-24